Why your body feels different after 40

The sleep is usually the first thing to shift. Not dramatic insomnia, but a quieter sense that rest no longer fully restores — waking at 3 am with a racing heart, or feeling wired and depleted at the same time. Then comes the mood that arrives without an obvious cause, the body reshaping itself despite no change in diet or routine, the brain that loses a word mid-sentence in a way it never used to.

The instinct is to attribute all of this to stress, overcommitment, or simply getting older. Those factors may be present — but beneath them, something more specific is shifting inside the body's chemistry. Hormones that have governed energy, mood, sleep architecture, and metabolism for decades are entering a period of genuine turbulence. This is perimenopause: a multi-year transition that can begin in the early-to-mid 40s, driven not by a smooth hormonal decline but by wild, erratic fluctuations in oestrogen and progesterone.

Professor Paul Lee's Regeneration by Design places hormones squarely within what he calls the Chemistry pillar — one of four interdependent levers (alongside Physics, which covers movement and physical energies; Biology, encompassing gut, sleep, and immunity; and Time, the art of monitoring and acting early) that together shape how the body ages. Understanding the chemistry storm of perimenopause is not cause for alarm; it is the starting point for navigating it by design.

The triple hormonal shift driving the storm

Think of oestrogen during perimenopause less as a dimmer switch gradually lowering and more as a thermostat with a faulty sensor — overshooting, overcorrecting, then crashing — sometimes within the same week. Levels can surge sharply before plummeting, which is why symptoms feel inconsistent and confusing rather than simply progressive. A hot flush one day and uncharacteristic calm the next is not random; it reflects genuine hormonal volatility.

Progesterone tends to fall first. As ovulation becomes irregular, the corpus luteum — the temporary gland that forms after each ovulation to produce progesterone — forms less reliably. With progesterone scarce, the body loses a critical calming mechanism: progesterone metabolises into allopregnanolone, a natural modulator of GABA-A receptors — the same receptors targeted by anti-anxiety medications. When progesterone drops, the nervous system loses its own built-in tranquiliser, which is why heightened anxiety, disrupted sleep, and a lowered threshold for overwhelm are often among the earliest signs of the transition.

Meanwhile, the pituitary gland senses the faltering ovarian response and raises follicle-stimulating hormone (FSH) in an attempt to drive production. FSH keeps climbing because the ovaries are no longer responding reliably — and its rise has become a measurable marker for staging where a woman is in the transition.

Together — volatile oestrogen, falling progesterone, rising FSH — these three shifts form the chemical engine behind hot flushes, night sweats, mood instability, brain fog, and menstrual irregularity. The word 'storm' is apt: this is not a single deficiency but overlapping, interacting signals reshaping the body's internal environment. In the language of Professor Paul Lee's Regeneration by Design, it is the Chemistry pillar under pressure — and understanding the mechanism is the first move in responding to it by design.

What the storm does to sleep and the brain

Around four in five perimenopausal women — some studies put the figure as high as nine in ten — report meaningful sleep disturbance. That statistic, drawn from a 2025 narrative review, is striking not just for its scale but for what it reveals: sleep disruption is not an incidental symptom of this transition; it is close to its defining one.

The mechanism is direct. Oestrogen and progesterone both play active roles in regulating sleep architecture. Oestrogen supports REM sleep and is involved in melatonin production; progesterone, as the triple hormonal shift described above erodes, removes GABA-pathway calming that governs sleep onset. When both hormones become erratic simultaneously, the body loses two independent sleep regulators at once — deep, restorative sleep fragments, and waking at 3 am with a mind already racing becomes a near-nightly pattern.

The consequences compound. Poor sleep worsens cognitive performance, destabilises mood, impairs insulin sensitivity, and raises inflammatory load — amplifying every other facet of the chemistry storm rather than simply sitting alongside it. Sleep is not one symptom among many; it is a force multiplier.

What is happening inside the brain is more complex than sleep deprivation alone. A 2024 PET imaging study found that oestrogen receptor density in key brain networks paradoxically increases during the transition — the brain effectively turning up its sensitivity to a more unpredictable signal. Higher receptor density correlated with poorer memory performance and predicted mood and cognitive difficulties in the post-menopausal years. Meanwhile, fluctuating oestrogen drives neuroinflammatory processes and reduces BDNF (brain-derived neurotrophic factor), a protein central to neuronal health and mood regulation. This gives perimenopausal brain fog and low mood a measurable neurochemical basis — not stress or life circumstance masquerading as biology, but genuine chemistry.

The Chemistry pillar connects here to Biology: sleep is also an ecosystem function, governing gut repair, immune calibration, and cellular recovery. The storm rarely stays in one pillar.

The metabolic reshaping most women are not warned about

Abdominal weight gain is one of the most commonly reported — and most poorly explained — changes women encounter during perimenopause. Many have not altered their diet or exercise habits, yet the waistline shifts. The explanation lies not in willpower or calories but in oestrogen's active metabolic role.

Oestrogen regulates insulin sensitivity and glucose metabolism. As levels become erratic and ultimately fall, insulin resistance rises — the body's cells respond less readily to insulin's signal, blood glucose stays elevated for longer, and fat storage increases. Resting energy expenditure also falls as muscle tissue thins. Simultaneously, fat distribution shifts — not uniformly, but preferentially toward visceral depots around the abdomen. This is a direct hormonal consequence of the chemistry storm, not simply a reflection of reduced activity or increased appetite.

Visceral fat is not passive. It is metabolically active, releasing pro-inflammatory signalling molecules that feed back into the inflammatory burden already raised by the transition. The storm, in other words, builds its own fuel.

A 2026 SWAN longitudinal study of 704 women adds a telling nuance: higher fasting insulin measured at around age 47 independently predicted an earlier onset, greater frequency, and longer duration of hot flushes and night sweats. Metabolic state does not merely accompany the perimenopausal transition — it actively shapes how severe the storm becomes. Supporting the body's insulin environment is an upstream lever, not an afterthought.

Muscle loss connects directly to the Physics pillar. As oestrogen declines, lean mass thins and resting metabolic rate drops further — which is why load-bearing movement and resistance training during this period are not simply physical goals but meaningful support for the body's internal chemical environment. In the framework Professor Paul Lee sets out in Regeneration by Design, this is the interdependence of the pillars made concrete: Chemistry under pressure is a Physics invitation.

Long-term stakes: what the chemistry storm restructures

Symptoms ease. They do not always last. But the chemistry storm's downstream effects on the body's architecture persist long after the transition itself — and this is the distinction that changes how perimenopause deserves to be understood.

Oestrogen quietly upholds cardiovascular integrity: it promotes vasodilation in coronary arteries through nitric oxide and prostacyclin, and acts as a systemic brake on inflammation. CVD in women runs roughly a decade behind men — a gap conferred largely by oestrogen's protective actions — and that gap narrows sharply after menopause. The cardiovascular risk shift does not begin post-menopause; it begins with the storm.

Bone follows a similar logic. Oestrogen restrains osteoclast activity — the cellular mechanism by which bone is broken down and resorbed. As oestrogen falters, osteoclasts work unchecked and bone mineral density falls. A 2025 SWAN study found that two biomarkers — Anti-Müllerian Hormone and the bone turnover marker CTX — can predict fast bone loss early in perimenopause, before it becomes clinically significant. That predictive window is precisely what the Time pillar is designed around: earlier signal, earlier response.

Migraines worsen too. Oestrogen volatility is a recognised migraine trigger; perimenopausal women — especially those with menstrual migraine — experience increased attack frequency and symptoms that are more disabling and less amenable to standard treatment than their pre-perimenopausal counterparts.

Then there is the broadest frame of all. A 2024 study tracking biological ageing across adulthood identified a measurable burst of accelerated systemic ageing around age 44 — closely overlapping the perimenopausal window. The chemistry storm is not a symptomatic pause between reproductive and later life; it is a period in which the body's longer-term trajectory is actively being rewritten. That is what makes early attention to the internal environment worth taking seriously now, and why anyone with specific health concerns should speak with a healthcare professional rather than simply wait it out.

Supporting your chemistry through the storm

Three levers stand out from the evidence — sleep, metabolic environment, and tracking — and each is more actionable than the transition itself might suggest.

Sleep first. The goal is not simply more hours but better architecture. Keeping a consistent sleep and wake time anchors circadian timing; limiting light exposure in the hour before bed supports melatonin production, which oestrogen fluctuations already suppress. Cooling the bedroom helps too — vasomotor events are harder to ride through against a warm ambient temperature. These adjustments are modest in effort and disproportionate in return, because sleep quality cascades into mood, cognition, and metabolic control simultaneously.

The metabolic lever. Building meals around adequate protein at each sitting — rather than concentrating intake late in the day — helps preserve lean muscle and moderate the post-meal insulin response. Reducing refined carbohydrate load steadies blood glucose, which matters more now that insulin sensitivity has shifted. Resistance training earns its place here as both a Physics intervention (load on bone and muscle) and a Chemistry one (improving insulin sensitivity and resting metabolic rate). This is the pillar interdependence Professor Paul Lee maps in Regeneration by Design: a Physics input shoring up the Chemistry environment, which in turn sustains sleep and cognition.

Monitoring as a practice. Keeping a simple log of menstrual pattern, sleep quality, and energy over a few months converts a confusing transition into readable data. Where clinically appropriate — and in conversation with a healthcare professional, including for questions about hormone therapy — tracking hormonal and metabolic markers can open earlier intervention windows, as the SWAN biomarker work on bone loss and vasomotor symptoms illustrates.

The biology of perimenopause is genuinely chaotic. But its upstream levers — insulin sensitivity, sleep architecture, muscle mass — are unusually responsive to early, consistent action, and the window to act is earlier than most women are told. Regeneration by Design and its follow-up Practical Regeneration offer the systemic framework for anyone who wants to meet this transition with design rather than simply endure it.

1. [1] Menopause-Associated Depression: Impact of Oxidative Stress and Neuroinflammation on the CNS — A Review. (2024). https://doi.org/10.3390/biomedicines12010184 https://doi.org/10.3390/biomedicines12010184
2. [2] In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology. (2024). https://doi.org/10.1038/s41598-024-62820-7 https://doi.org/10.1038/s41598-024-62820-7
3. [3] European Society of Endocrinology Clinical Practice Guideline for Evaluation and Management of Menopause and the Perimenopause. (2025). https://doi.org/10.1093/ejendo/lvaf206 https://doi.org/10.1093/ejendo/lvaf206
4. [4] Estrogen and Metabolism: Navigating Hormonal Transitions from Perimenopause to Postmenopause. (2025). https://doi.org/10.4103/jmh.jmh_75_25 https://doi.org/10.4103/jmh.jmh_75_25
5. [5] Sleep Disturbance and Perimenopause: A Narrative Review. (2025). https://doi.org/10.3390/jcm14051479 https://doi.org/10.3390/jcm14051479
6. [6] Insulin Levels Early in Perimenopause Inform Vasomotor Symptom Incidence Across the Menopausal Transition (SWAN). (2026). https://doi.org/10.1210/clinem/dgaf699 https://doi.org/10.1210/clinem/dgaf699
7. [7] Sex and Sex Steroids as Determinants of Cardiovascular Risk. (2024). https://doi.org/10.1016/j.steroids.2024.109423 https://doi.org/10.1016/j.steroids.2024.109423
8. [8] The Role of Menopausal Hormone Therapy in Prevention and Treatment of Low Bone Density in Perimenopausal and Postmenopausal Women. (2023). https://doi.org/10.1097/GCO.0000000000000858 https://doi.org/10.1097/GCO.0000000000000858
9. [9] Anti-Mullerian Hormone and Collagen Type I C-telopeptide Predict Fast, Imminent Bone Loss in Early Perimenopause: SWAN. (2025). https://doi.org/10.1210/clinem/dgaf658 https://doi.org/10.1210/clinem/dgaf658
10. [10] Menopause Triggers Microglia-Associated Neuroinflammation in Parkinson's Disease. (2025). https://doi.org/10.1016/j.brainres.2025.149649 https://doi.org/10.1016/j.brainres.2025.149649